AI Science Tracker
EN

Hangzhou Dianzi University, Automation College, Hangzhou, Zhejiang, China

1 discovery from 2023

Discoveries

Quantifying the drug response of patient-derived organoid clusters by aggregated morphological indicators with multi-parameters based on optical coherence tomography.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: EGO-Net segmented OCT images and quantified organoid morphology; PCA aggregated longitudinal indicators correlated >0.90 with ATP viability tests in colorectal cancer organoids from three patients, and response varied across drug doses/combinations. Full Methods/Results read. Very small in-vitro sample; no claim of patient treatment benefit.

Technology: Machine-learning analysis applies the stated model to the paper’s medicine dataset and evaluates the reported outcome.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Machine-learning analysis applies the stated model to the paper’s medicine dataset and evaluates the reported outcome.
Limitation / still unknown
Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10110317/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.